Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause Article

publication date

  • 2016

webpage

keywords

  • Dehydroepiandrosterone
  • Dryness
  • Dyspareunia
  • Genitourinary syndrome of menopause
  • Intracrinology
  • Prasterone
  • Vulvovaginal atrophy

start page

  • 243

end page

  • 256

volume

  • 23

issue

  • 3